Are biosimilars of high quality?
All biological medicines, including biosimilars, manufactured in Europe are made according to current Good Manufacturing Practice (cGMP), which dictates that they are produced consistently and to a high quality standard. Manufacturing facilities are subject to routine cGMP and Pre-Approval Inspections (PAI) for cGMP compliance, therefore ensuring that high standards are in place.
